申请人:CARNA BIOSCIENCES, INC.
公开号:US10793575B2
公开(公告)日:2020-10-06
An oxoisoquinoline compound of the following formula:
or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the oxoisoquinoline compound or salt; and a method for treating B-cell lymphoma comprising administering the oxoisoquinoline compound or salt to a patient.
一种下式的氧化异喹啉化合物:
或其药学上可接受的盐;包含该氧化异喹啉化合物或盐的药物组合物;以及治疗 B 细胞淋巴瘤的方法,包括向患者施用该氧化异喹啉化合物或盐。